Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model.
about
Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice.Probiotics and medical nutrition therapyPotential uses of probiotics in clinical practiceFermented Foods: Are They Tasty Medicines for Helicobacter pylori Associated Peptic Ulcer and Gastric Cancer?Probiotics for the treatment of Helicobacter pylori infection in childrenImpact of lactose containing foods and the genetics of lactase on diseases: an analytical review of population data.Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LBIdentification of Lactobacillus strains with probiotic features from the bottlenose dolphin (Tursiops truncatus)Probiotic agents and infectious diseases: a modern perspective on a traditional therapy.Human embryonic gastric xenografts in nude mice: a new model of Helicobacter pylori infection.The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota.Review article: should we kill or should we save Helicobacter pylori?Genomic and phenotypic evidence for probiotic influences of Lactobacillus gasseri on human health.Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia.Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans.The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesisRole of apoptosis induced by Helicobacter pylori infection in the development of duodenal ulcer.In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota.A highly acid-resistant novel strain of Lactobacillus johnsonii No. 1088 has antibacterial activity, including that against Helicobacter pylori, and inhibits gastrin-mediated acid production in mice.Marked seasonal variation in the wild mouse gut microbiota.Improved Helicobacter pylori Eradication Rate of Tailored Triple Therapy by Adding Lactobacillus delbrueckii and Streptococcus thermophilus in Northeast Region of Thailand: A Prospective Randomized Controlled Clinical Trial.Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.Functional foods: a survey of health claims, pros and cons, and current legislation.Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy.Probiotics: their role in the treatment and prevention of disease.Effects of Lactobacillus gasseri OLL2716 on Helicobacter pylori-Associated Dyspepsia: A Multicenter Randomized Double-Blind Controlled TrialDietary and socio-economic factors in relation to Helicobacter pylori re-infection.Long-Term Use of Probiotic-Containing Yogurts Is a Safe Way to Prevent Helicobacter pylori: Based on a Mongolian Gerbil's Model.Dairy consumption and gastric cancer risk: a meta-analysis of epidemiological studies.Role of indigenous lactobacilli in gastrin-mediated acid production in the mouse stomach.Potential role of probiotics in the management of gastric ulcer.Use of selected lactic acid bacteria in the eradication of Helicobacter pylori infection.Saccharomyces boulardii expresses neuraminidase activity selective for α2,3-linked sialic acid that decreases Helicobacter pylori adhesion to host cells.Mouse Models for Assessing the Protective Efficacy of Lactobacillus gasseri SBT2055 against Helicobacter suis Infection Associated with the Development of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines.Antagonistic activities of lactobacilli against Helicobacter pylori growth and infection in human gastric epithelial cells.A euthymic hairless mouse model of Helicobacter pylori colonization and adherence to gastric epithelial cells in vivo.Ammonia as an accelerator of tumor necrosis factor alpha-induced apoptosis of gastric epithelial cells in Helicobacter pylori infection.Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology.Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane.
P2860
Q24535026-4F9766DC-F078-446F-917B-89736B457F3CQ24548441-066D6A8C-6A48-4041-A60F-17A34283F8F1Q24681377-EB3D7CAE-AE1B-410C-AE6E-45B8D836EA6EQ26738441-94F75F30-A8A9-4A04-9C6F-DDDFDFBD8882Q26825005-65ED0A56-5319-46E4-BF78-52DDC58D6A5BQ31153865-C2FD4303-A4C9-4D8A-949F-BE4484B0FE53Q33719312-C5FB6FD2-BF72-426D-8668-83363A7F4192Q33777194-08235278-13A0-4D4F-9087-583707C5DBB4Q33945722-D5D240D4-AAE2-4B58-993F-FEF1B4767B5CQ34000880-1A087907-A275-49B4-8330-B807E5CFB1D0Q34156291-27F26EA4-B3D2-42E2-8DBD-4A30B6FCA368Q34327982-BABC6AC6-FAC0-4BE8-A563-7FBA0B42159DQ34332869-0C477985-22E1-491D-B8C1-9FF69206C9ECQ34427123-198B9851-F48E-4D23-A9F2-05BFFEAF4EE4Q34512635-4B481EB1-5355-4FB2-A1ED-3068EAB0C662Q34959399-B2AD3EE9-63BF-45FE-AD40-DA592F55FD97Q35354731-16794EAE-6FEB-42EA-9DE7-A15870F8FC0DQ35539059-61C36AE0-3D6B-4340-B5EB-8ACA8660A503Q35577427-C49D171F-E27E-48D8-9917-9B7C737272F0Q35646012-636A731B-551C-4A84-9BD7-A72A4CD620B1Q35763686-17DE39B2-3A34-4212-804B-CD52F95BBD3EQ35890738-7FC8BA1E-63A8-427F-8E58-53B732F1E358Q36244329-FDEEFFB1-10FE-43D9-A114-6930B5DE68E3Q36417791-C9FE99A9-8C61-40A1-A18F-A6FAC92E8BBBQ36441502-0D0FD364-AF64-4D7C-8B7D-A93BFC88BB59Q37120818-74B89707-9AF1-47C6-918C-BFCF2F9E2CEFQ37127152-01B26E3D-4FC9-42E8-A0CB-4D4C3FA11BC0Q37375658-C451CB35-DCF0-469D-8B15-227E251BE2D4Q38449188-6BE126F5-212B-449B-92E4-E9BF9709F89FQ38628092-DC924DFE-59B2-4F47-8159-703CEA02CE14Q38848225-152633C5-F6D4-4C4C-B066-9EEBDABBDC00Q38951065-C2E9AD17-939A-4986-9F91-BC8D95C25E0CQ39015593-A9EE836B-490B-4303-BB23-3A67C98C3180Q39130319-BBDA9F8B-9A34-4CBE-B1EA-E0A06B37F827Q39260465-332AC84D-E93A-4662-813F-AF52FC2134BBQ39425803-2E979E5E-F974-4B57-8479-3926F18BFE44Q39505893-77DA4898-3F45-49FB-AF2B-1DE6227B14E8Q39518232-24F11D70-4FB6-44BC-85B5-1BD6BF5F2108Q39523461-AEC4214E-716D-4639-8E8E-D89DBF55698DQ39536265-EBDEB5E2-D23C-4640-B62F-487B1308C3D9
P2860
Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Prevention of Helicobacter pyl ...... in a gnotobiotic murine model.
@en
Prevention of Helicobacter pyl ...... in a gnotobiotic murine model.
@nl
type
label
Prevention of Helicobacter pyl ...... in a gnotobiotic murine model.
@en
Prevention of Helicobacter pyl ...... in a gnotobiotic murine model.
@nl
prefLabel
Prevention of Helicobacter pyl ...... in a gnotobiotic murine model.
@en
Prevention of Helicobacter pyl ...... in a gnotobiotic murine model.
@nl
P2093
P2860
P356
P1433
P1476
Prevention of Helicobacter pyl ...... in a gnotobiotic murine model.
@en
P2093
P2860
P356
10.1136/GUT.41.1.49
P407
P577
1997-07-01T00:00:00Z